HERA FIb Registry for Patients With Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT05995561
- Lead Sponsor
- University Hospital Heidelberg
- Brief Summary
The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg
- Detailed Description
HERA AFIb is a single-center retrospective registry which enrolled consecutive cases presenting with atrial fibrillation at the emergency department of University Hospital of Heidelberg. Clinical parameters and characteristics for cases were assessed retrospectively. Follow-up was performed via review of medical reports, phone calls and postal queries. Outcome parameters included rates for all-cause mortality, non-hemorrhagic stroke, myocardial infarction and major bleeding.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12297
- documented atrial fibrillation
- availability of at least one hsTnT measurement
- lost to follow-up
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method all-cause mortality 24 months all-cause mortality during follow-up
- Secondary Outcome Measures
Name Time Method major bleeding 24 months major bleeding during follow-up
ischaemic stroke 24 months ischaemic stroke during follow-up
myocardial infarction 24 months myocardial infarction during follow-up
Trial Locations
- Locations (1)
University Hospital of Heidelberg
🇩🇪Heidelberg, Baden-Württemberg, Germany
University Hospital of Heidelberg🇩🇪Heidelberg, Baden-Württemberg, Germany